Atea Pharmaceuticals (AVIR) Treasury Shares (2022 - 2026)

Atea Pharmaceuticals' Treasury Shares history runs 5 years deep, the most recent figure standing at $4.0 million for Q1 2026.

• In Q1 2026, Treasury Shares rose 61.79% year-over-year to $4.0 million; the TTM figure through Mar 2026 stood at $4.0 million (up 61.79% YoY), while the FY2025 annual figure was $2.5 million, up 38.32% from the prior year.
• Treasury Shares was $4.0 million for Q1 2026 at Atea Pharmaceuticals, up from $2.5 million in the prior quarter.
• In the past five years, Treasury Shares ranged from a high of $4.0 million in Q1 2026 to a low of $724970.0 in Q4 2022.
• Historically, Treasury Shares has averaged $2.2 million across 5 years, with a median of $2.4 million in 2023.
• The sharpest annual moves came in 2024 and 2025: Treasury Shares soared 145.92% in 2024, then slipped 10.94% in 2025.
• A 5-year view of Treasury Shares shows it stood at $724970.0 in 2022, then changed by 0.0% to $724970.0 in 2023, then jumped by 145.92% to $1.8 million in 2024, then soared by 38.32% to $2.5 million in 2025, then soared by 61.79% to $4.0 million in 2026.
• The last three Treasury Shares figures came in at $4.0 million (Q1 2026), $2.5 million (Q4 2025), and $2.2 million (Q3 2025), per Business Quant data.